Editorial: Telomere shortening and regenerative capacity afteracute kidney injury

Journal of the American Society of Nephrology

Volumn 21, Issue 2, 2010, Pages 202-204

  Wills, Lauren P ^a   Schnellmann, Rick G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; RNA; TELOMERASE RNA;

APOPTOSIS; CHROMOSOME; CONVALESCENCE; EDITORIAL; ENZYME ACTIVITY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; PRIORITY JOURNAL; REPERFUSION INJURY; TELOMERE; ACUTE KIDNEY FAILURE; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; KIDNEY; METABOLISM; MOUSE; MOUSE MUTANT; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; MICE; MICE, KNOCKOUT; REGENERATION; REPERFUSION INJURY; RNA; TELOMERASE; TELOMERE;

EID: 77949349091     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009121270     Document Type: Editorial

References (20)

1. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG: The aging kidney. Kidney Int 74: 710-720, 2008
2. Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J: Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 20: 2214-2222, 2009
3. Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, Rifkin D, Sarnak MJ: Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 20: 2625-2630, 2009
4. Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC: Association of CKD and cancer risk in older people. J Am Soc Nephrol 20: 1341-1350, 2009
5. Khatri M, Nickolas T, Moon YP, Paik MC, Rundek T, Elkind MS, Sacco RL, Wright CB: CKD associates with cognitive decline. J Am Soc Nephrol 20: 2427-2432, 2009
6. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223-228, 2009
7. Ju Z, Rudolph KL: Telomeres and telomerase in stem cells during aging and disease. Genome Dyn 1: 84-103, 2006
8. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985
9. Westhoff JH, Schildhorn C, Jacobi C, Homme M, Hartner A, Braun H, Kryzer C, Wang C, von Zglinicki T, Kranzlin B, Gretz N, Melk A: Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 21: 327-336, 2010
10. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA: Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574, 1998
11. Satyanarayana A, Wiemann SU, Buer J, Lauber J, Dittmar KE, Wustefeld T, Blasco MA, Mans MP, Rudolph KL: Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J 22: 4003-4013, 2003
12. Joaquin AM, Gollapudi S: Functional decline in aging and disease: A role for apoptosis. J Am Geriatr Soc 49: 1234-1240, 2001
13. Zhang, J-H, Zhang Y, Herman B: Caspases, apoptosis and aging. Ageing Res Rev 2: 357-366, 2003
14. Carr MW, Alon R, Springer TA: The C-C Chemokine MCP-1 differentially modulates the avidity of beta1 and beta2 integrins on T lymphocytes. Immunity 4: 179-187, 1996
15. Feitoza CQ, Gonçalves GM, Semedo P, Cenedeze MA, Pinheiro HS, Beraldo FC, dos Santos OF, Teixeira Vde P, dos Reis MA, Mazzali M, Pacheco-Silva A, Câmara NO: Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis. Mol Med 14: 724-730, 2008
16. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL: Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 54: 2152-2159, 1998
17. Melk A: Senescence of renal cells: Molecular basis and clinical implications. Nephrol Dial Transplant 18: 2474-2478, 2003
18. Melk A, Halloran PF: Cell senescence and its implications for ne-phrology. J Am Soc Nephrol 12: 385-393, 2001
19. Covington MD, Arrington DD, Schnellmann RG: Calpain 10 is required for cell viability and is decreased in the aging kidney. Am J Physiol Renal Physiol 296: F478-F486, 2009
20. Yang HC, Deleuze S, Zuo Y, Potthoff SA, Ma LJ, Fogo AB: The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol 20: 2380-2388, 2009